Bioadaptives (BDPT) EBIAT (2019 - 2025)
Bioadaptives' EBIAT history spans 7 years, with the latest figure at -$379502.0 for Q3 2025.
- For Q3 2025, EBIAT fell 908.0% year-over-year to -$379502.0; the TTM value through Sep 2025 reached -$1.1 million, down 39.04%, while the annual FY2024 figure was -$899161.0, 26.2% down from the prior year.
- EBIAT for Q3 2025 was -$379502.0 at Bioadaptives, down from -$157914.0 in the prior quarter.
- Across five years, EBIAT topped out at -$13061.0 in Q3 2023 and bottomed at -$491903.0 in Q1 2021.
- The 5-year median for EBIAT is -$223837.0 (2022), against an average of -$225878.8.
- The largest annual shift saw EBIAT skyrocketed 95.27% in 2023 before it crashed 908.0% in 2025.
- A 5-year view of EBIAT shows it stood at -$214283.0 in 2021, then soared by 86.8% to -$28277.0 in 2022, then plummeted by 848.83% to -$268301.0 in 2023, then plummeted by 38.57% to -$371788.0 in 2024, then decreased by 2.07% to -$379502.0 in 2025.
- Per Business Quant, the three most recent readings for BDPT's EBIAT are -$379502.0 (Q3 2025), -$157914.0 (Q2 2025), and -$197136.0 (Q1 2025).